Algernon Pharmaceuticals (AGNPF)
OTHER OTC:AGNPF

Algernon Pharmaceuticals (AGNPF) Balance Sheet

72 Followers

Algernon Pharmaceuticals Balance Sheet

Algernon Pharmaceuticals's total assets for Q2 2024 were C$3.95M, an increase of 0.06% from the previous quarter. AGNPF total liabilities were C$3.52M for the fiscal quarter, a 19.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Aug 23Aug 22Aug 21Aug 20Aug 19
Total Assets
C$ 4.19MC$ 8.14MC$ 10.14MC$ 12.82MC$ 5.34M
Total Liabilities
C$ 2.72MC$ 2.52MC$ 1.02MC$ 607.05KC$ 365.46K
Total Equity Gross Minority
C$ 1.47MC$ 5.62MC$ 9.12MC$ 12.22MC$ 4.97M
Total Capitalization
C$ 1.47MC$ 5.62MC$ 9.12MC$ 12.22MC$ 4.97M
Preferred Stock Equity
-----
Capital Lease Obligations
-----
Currency in CAD

Algernon Pharmaceuticals Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis